Author

P G Steg

Observed name: P Steg

Institutions: Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Laboratoire de Recherche Vasculaire Translationnelle, Hôpital Bichat-Claude-Bernard, Université Paris Diderot

Observed institutions: Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Laboratoire de Recherche Vasculaire Translationnelle, Hôpital Bichat-Claude-Bernard, Université Paris Diderot

OpenAlex ID: A5159496344

Anthropometric parameters and long-term mortality in patients admitted for acute myocardial infarction: results from FAST-MI registries

2026 · J Mesnier, T Simon, et al. · European Heart Journal

What is the representation of women in acute myocardial infarction in “real life” ? Insights from the population-based French national healthcare database 2016-2022

2026 · P Steg, S Zendjebil, et al. · European Heart Journal

Evolution of anthropometrics parameters in overweight patients with chronic coronary syndromes

2026 · J Mesnier, N Danchin, et al. · European Heart Journal

Impact of anthropometric parameters in patients with chronic coronary syndromes: insights from the CLARIFY registry

2026 · J Mesnier, N Danchin, et al. · European Heart Journal

Longitudinal trends in statin prescribing and LDL-C control prior to acute myocardial infarction (AMI) in France: we continue to “miss the mark”

2026 · P G Piriou, J Mesnier, et al. · European Heart Journal

Lipoprotein(a), smoking, and diabetes are additive, but not interactive risk factors for major adverse cardiovascular events after acute coronary syndrome: An analysis of the ODYSSEY OUTCOMES trial

2026 · G G Schwartz, M Szarek, et al. · European Heart Journal

Sex- and age-based disparities in statin use in patients admitted for acute myocardial infarction in France: two decades of failure ?

2026 · P G Piriou, N Danchin, et al. · European Heart Journal

Lipoprotein(a) variability in high CV risk patients with hypertriglyceridemia and controlled LDL-C on statin therapy – REDUCE-IT Lp(a) Variability

2026 · M Szarek, D L Bhatt, et al. · European Heart Journal

Adherence and legacy effects of high dose eicosapentaenoic acid in hypertriglyceridemia and high CV risk – REDUCE-IT Legacy

2026 · C Packard, P G Steg, et al. · European Heart Journal

Association of lipoprotein(a) levels with risk of serious bleeding : findings from the ODYSSEY OUTCOMES trial

2026 · P Steg, M S Szarek, et al. · European Heart Journal

Variability in lipoprotein(a) measurements in ODYSSEY OUTCOMES: is one-and-done testing sufficient?

2026 · M Szarek, P G Steg, et al. · European Heart Journal

Works count: 11

Citation count:

H-index:

I10-index: